Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2022
Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trialsMarkus Diefenhardt, Maximillian Fleischmann, Daniel Martin, et al.
Frontiers in Oncology|September 3, 2019
Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and BrachytherapyMax Fleischmann, Daniel Martin, Samuel Peña-Llopis, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2025
Quality of Life After Two Sequences of Total Neoadjuvant Treatment in Patients With Locally Advanced Rectal Cancer in the Randomized CAO/ARO/AIO-12 Phase 2 TrialRebekka Kosmala, Adriana Salazar Hammann, Patrick Paulus, et al.
Oral Oncology|March 27, 2025
Neoadjuvant chemoradiation for patients with resectable locally advanced oral cavity squamous cell carcinoma: Results of the prospective INVERT clinical trialMaximilian Fleischmann, Alexander Kristen, Ria Winkelmann, et al.
Scientific Reports|June 17, 2022
Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics modelsIram Shahzadi, Alex Zwanenburg, Annika Lattermann, et al.
Journal of Cancer Research and Clinical Oncology|October 25, 2025
Quality of life following total neoadjuvant therapy for rectal cancerGeorg W Wurschi, Markus Diefenhardt, Justus Kaufmann, et al.
International Journal of Cancer|March 15, 2019
Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trialMarkus Diefenhardt, Ralf-Dieter Hofheinz, Daniel Martin, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2024
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trialsEmmanouil Fokas, Hannah Williams, Markus Diefenhardt, et al.
The Lancet. Gastroenterology & Hepatology|May 10, 2025
Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trialCihan Gani, Emmanouil Fokas, Bülent Polat, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trialsDario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Pageof 4